Skip to content

Exploring attention mechanisms in children with cochlear implants: a study on neural markers

Neural Markers of Attention Processing in Cochlear Implant Users (NMAP-CI): an event-related potential study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN14072313
Enrollment
53
Registered
2025-04-17
Start date
2022-08-10
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Auditory attention processing in prelingually deaf children with bilateral cochlear implants Ear, Nose and Throat

Interventions

This cross-sectional study examines neural mechanisms of attention in pediatric cochlear implant users through event-related potentials, focusing on the Novelty P3 (automatic attention) and Target P3

Sponsors

Hadassah Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Cochlear Implant (CI) Group: 1. Prelingually deaf children 2. Bilateral cochlear implant users 3. Age range 7-14 years 4. Minimum 4 years of CI experience 5. Regular CI users with consistent device use For Normal-Hearing (NH) Control Group: 1. Age-matched children: 2. Normal hearing thresholds (=20 dB HL across frequencies) 3. No history of hearing disorders 4. No neurological disorders General Criteria for Both Groups: 1. No additional disabilities 2. Normal cognitive development 3. Written informed consent from parents/guardians 4. Ability to follow test instructions 5. Native language (Hebrew or Arabic speakers, balanced between groups)

Exclusion criteria

Exclusion criteria: For Both Groups: 1. Additional disabilities beyond hearing loss (for the CI group) 2. Diagnosed neurological disorders 3. Cognitive impairments 4. Attention deficit disorders 5. Inability to complete all testing sessions Specific to CI Group: 1. Irregular/inconsistent CI use 2. Device complications or malfunctions 3. Post-lingual deafness 4. Unilateral cochlear implant Specific to NH Control Group: 1. Any history of hearing loss 2. Hearing thresholds >20 dB HL at any frequency 3. History of middle ear pathology 4. Current or recent use of medications affecting cognitive function

Design outcomes

Primary

MeasureTime frame
1. Automatic attention processing is measured using frontal Novelty P3 amplitudes and latencies from ERP recordings during an oddball paradigm at one testing session 2. Controlled attention processing is measured using parietal Target P3 amplitudes and latencies from ERP recordings during an oddball paradigm at one testing session

Secondary

MeasureTime frame
1. Speech perception in noise is measured using the Speech-in-Noise test at one testing session 2. Short-term memory capacity is measured using Forward Digit Span and working memory capacity is measured using Backward Digit Span (test at one testing session)

Countries

Israel

Contacts

Public ContactOla Badarni-Zahalka
ola.badarni6@gmail.com+972 (0)5454658184

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026